SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
NCT06344832 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-04-03
Summary
The research aims to prospectively include patients with GEP-NENs, undergo preoperative imaging assessment (including PET/CT and contrast-enhanced CT), and accurately delineate lymph node regions. Through postoperative pathological reports, the diagnostic performance of lymph node metastasis (LNM) in GEP-NENs is evaluated. Factors influencing the diagnostic accuracy of SSTR-PET/CT and contrast-enhanced CT are also investigated.
Conditions
- Gastro-entero-pancreatic Neuroendocrine Tumor
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2028-03-01
- Completion
- 2030-03-01
More Related Trials
-
Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.
NCT06435741 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)
NCT03244566 ·Status: COMPLETED
-
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
NCT04152928 ·Status: UNKNOWN ·Phase: NA
-
[68 Ga]-DOTANOC PET/CT in GEP-NETs
NCT02608203 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan
NCT03136328 ·Status: COMPLETED ·Phase: PHASE3
-
Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma Patients
NCT04394091 ·Status: UNKNOWN
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126 ·Status: RECRUITING
-
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
NCT04804371 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
NCT05749289 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
NCT07102056 ·Status: NOT_YET_RECRUITING
-
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
NCT04069299 ·Status: COMPLETED
-
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
NCT02078843 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
NCT00885248 ·Status: UNKNOWN
-
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694 ·Status: RECRUITING
-
The Predictive Value of CT-PET in Esophageal Cancer
NCT02385604 ·Status: COMPLETED
-
PD-L1 Targeting Molecular Imaging of Solid Tumors
NCT04629326 ·Status: RECRUITING ·Phase: NA
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
18F-LN1 PET/CT in Urothelial Carcinomas
NCT06120413 ·Status: RECRUITING
-
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
NCT05673031 ·Status: RECRUITING
-
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy
NCT04913896 ·Status: UNKNOWN
-
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
NCT05722275 ·Status: RECRUITING
-
PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
NCT03271281 ·Status: COMPLETED ·Phase: PHASE2
-
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
NCT06644274 ·Status: RECRUITING
-
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
NCT06448208 ·Status: ACTIVE_NOT_RECRUITING